spacer
home > pmps > winter 2001 > medical and pharmaceutical translation - the need for a specialist
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Medical and Pharmaceutical Translation - The Need for a Specialist

The globalisation of business has led to the need for the medical and pharmaceutical industries to simultaneously satisfy the requirements of regulatory authorities, including submission of information in a variety of languages. For example, those pharmaceutical companies submitting a marketing authorisation application in order to fulfil EU dossier requirements must provide a summary of product characteristics (Part IB), labelling information and a patient information leaflet in every official EU language. In addition, there are often layout requirements and the need to use phrase constructions that are fixed and mandatory. Finally, similar requirements also apply to CE Marking related documentation for the medical devices market. Only a professional and specialised company can provide the expertise needed for this sort of demanding translation work.

To work as a translator, a person must not only be fluent in multiple languages, but also have the academic foundation upon which to base a thorough understanding of the current status and terminology of highly specialised areas of business, law, technology, economy and health care. The translator must have a solid linguistic education.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Arthur P. Leccese of Wilkens c.s. in the Netherlands Dr Arthur P. Leccese holds a PhD in Physiological Psychology. For two decades, he conducted research and taught courses in psychopharmacology in the US After working with several pharmaceutical firms in the Netherlands, he joined Wilkens c.s. as a Translator of medical-pharmaceutical texts.
spacer
Arthur P. Leccese
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals receives FDA approval

[Pamplona, September 16th, 2019] 3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organisation (CDMO) specialized in process development and GMP manufacturing of biologics, receives FDA approval after completing the Pre-Approval Inspection (PAI) conducted at the 3P drug substance manufacturing facility.
More info >>

White Papers

Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences

CIDP (Centre International de Développement Pharmaceutique)

Mauritius, the tropical island situated in the Indian Ocean and known worldwide for its beautiful beaches, is also internationally recognised for its rule of law, and political and social stability. Over the past few years, the economy has been successfully transitioned from a monocrop to a diversified innovation-driven and knowledge-based economy, resting on agribusiness, export-oriented manufacturing, tourism, financial services, property development and real estate, ICT-BPO, the seafood industry, a free port, logistics and a nascent ocean economy. Emerging sectors such as healthcare and life sciences are presenting some niche areas for the taking, and the enabling environment is being put in place to make it happen - especially in the light of sustained growth within pharmaceutical, medical device, and clinical research. Important international players are already in operation locally as the country has established the appropriate legal and regulatory frameworks based on international norms, for the development of a strong biomedical research sector.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement